Back

Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation

12 May 2024 (15:00 - 15:09)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 3 Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Veneta Dimitrova

University Hospital Alexandrovska, Sofia (Bulgaria)

4 More presentations in this session

Presentation thumbnail
Multidisciplinary approach in cardio-oncology: putting words into action
Doctor A. Pons Riverola (Barcelona, ES)
Slides Video
Presentation thumbnail
Levosimendan use in anthracycline-induced cardiomyopathy: reversing the irreversible ?
Doctor V. Tassi (Athens, GR)
Slides Video
Presentation thumbnail
Immune checkpoint inhibitor-associated myocarditis: a rare presentation with electrical storm in a young patient with Hodgkin lymphoma
Doctor A. Stavrati (Thessaloniki, GR)
Slides Video
Presentation thumbnail
Anthracycline chemotherapy-related cardiac dysfunction? It is not always what it seems
Doctor S. Jimenez-Marrero (Barcelona, ES) Doctor H. Morillas Climent (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 3

The Event

Event poster

Heart Failure 2024

12 May 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
The clinical conundrum of electrical and mechanical myocardial dysfunction complicated by cancer therapy: a collaborative multidisciplinary approach to achieve the best possible patient outcome
thumbnail
Congress Presentation
Case 1 - atrial fibrillation and heart failure on trastuzumab: a reversible storm navigated by the Maltese cardio-oncology teams
thumbnail
Congress Session
Cardiac effects of cancer therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources